English | Español
Patient Daily | Jan 23, 2026

DLL3 marker on blood tumor cells helps identify lung cancer patients likely to benefit from tarlatamab
Patient Daily | Jan 23, 2026

Cancer death rate falls by one-third since early nineties but gaps remain
Patient Daily | Jan 23, 2026

Study examines how environment, technology shape runners' experiences in Vancouver
Patient Daily | Jan 23, 2026

Monash calls for funding national genomic screening after pilot reveals undetected risks
Patient Daily | Jan 23, 2026

UCL researchers identify natural molecule pathway regulating inflammation
Patient Daily | Jan 23, 2026

New oral drug shows promise for lowering blood lipids in early clinical trial
Patient Daily | Jan 23, 2026

University of Liverpool study links post-meal blood sugar spikes to Alzheimer’s risk
Patient Daily | Jan 23, 2026

Researchers create 3D-printed microscopic structures inside living cells

Trending
+ Pharmaceuticals
Patient Daily | Jan 30, 2026

Senate gridlock delays decision on rare disease priority review voucher program
+ Pharmaceuticals
Patient Daily | Feb 2, 2026

Clinical trial landscape shifts globally as China increases role in innovation
+ Pharmaceuticals
Patient Daily | Feb 3, 2026

Drug Channels President on 340B: 'no one knows where the 340B profits go, or which patients benefit'
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Summit Therapeutics’ ivonescimab faces key FDA decision as potential Keytruda competitor